CreditReports.dk
HomeScreen companies

CSL PHARMA-ADVICE ApS Financials, key figures and credit report

CVR number: 36501693 Established 2015 Industry: 70 Activities of head offices and management consultancy
Company contact details
Birkevej 4, Åvang 4320 Lejre
Gross profit 30.6 kDKK FY 2022 +188.2% vs 2021
EBIT 30.6 kDKK FY 2022 +188.2% vs 2021
Net debt - 127.5 kDKK FY 2022 +53.4% vs 2021
Quick ratio 21.2 FY 2022 -6 vs 2021

Company information

Official name
CSL PHARMA-ADVICE ApS
Established
2015
Domicile
Åvang
Company form
Private limited company
Industry

Data sources and methodology

The information about CSL PHARMA-ADVICE ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2022.

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About CSL PHARMA-ADVICE ApS

CSL PHARMA-ADVICE ApS (CVR number: 3650169-3) is a company from LEJRE. The company recorded a gross profit of 30.6 kDKK in 2022. The operating profit was 30.6 kDKK, while net earnings were 32.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 14.7 %, which can be considered good but Return on Equity (ROE) was 16.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 95.3 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. CSL PHARMA-ADVICE ApS's liquidity measured by quick ratio was 21.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Net sales (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2018
2019
2020
2021
2022
Volume
Net sales399.61261.33143.18
Gross profit280.54180.5294.98-34.6930.60
EBIT280.54180.5294.98-34.6930.60
Net earnings214.34134.5870.72-44.5332.50
Shareholders equity total545.62480.20420.91266.39133.89
Balance sheet total (assets)589.61555.60449.54276.56140.52
Net debt- 582.15- 538.83- 426.22- 273.51- 127.48
Profitability
EBIT-%70.2 %69.1 %66.3 %
ROA44.1 %31.5 %18.9 %-9.6 %14.7 %
ROE38.4 %26.2 %15.7 %-13.0 %16.2 %
ROI51.0 %35.2 %21.1 %-10.1 %15.3 %
Economic value added (EVA)206.04138.7276.08-34.4230.96
Solvency
Equity ratio92.5 %86.4 %93.6 %96.3 %95.3 %
Gearing
Relative net indebtedness %- 134.7 %- 177.3 %- 277.7 %
Liquidity
Quick ratio13.47.415.727.221.2
Current ratio13.47.415.727.221.2
Cash and cash equivalents582.15538.83426.22273.51127.48
Capital use efficiency
Trade debtors turnover (days)
Net working capital %136.5 %183.7 %294.0 %

Variable visualization

ROA FY 2022
14.7%
Rating 66/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2022
95.3%
Rating 76/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of CSL PHARMA-ADVICE ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Companies in the same industry

Page generated